Taletrectinib is intended for Pharmaceuticals applications. Taletrectinib is a new-generation selective ROS1/NTRK inhibitor, orally available, that is being developed to treat people who have metastatic ROS1+ NSCLC. All information about Taletrectinib is provided in the MSDS. We deliver compounds with high purity levels and a comprehensive Certificate of Analysis. Connect to your member account to consult the documents.

规格	1 mg
稳定性	≥ 1 year